Plaque Psoriasis

Six Ways Psoriasis Costs Extend Well Beyond Treatment of One Condition

October 19, 2018

Individuals with immune-mediated diseases, such as psoriasis, are at higher risk for having other immune-mediated diseases. Here’s how psoriasis can lead to other conditions, and the associated costs.

Plaque Psoriasis

October 18, 2018

Opinion: Time to Manage ‘Clinically Superfluous’ Drug Products to Control Costs

March 29, 2018

PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.

How telemedicine will change care delivery and costs in 2018

February 01, 2018

Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.

Will biosimilars deliver on expectations?

January 06, 2018

This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.

New challenges, opportunities in autoimmune disease treatment

August 24, 2017

Allegheny Health Network’s Susan Manzi, MD, MPH, discusses the healthcare needs of patients with lupus and other autoimmune disorders.

Autoimmune drug pipeline: What health execs should watch

May 06, 2017

New drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease-some recently approved and others coming down the pipeline-could have an impact on the industry.

Watch list 2017: Top therapeutic areas

January 03, 2017

Find out about the latest treatment and drug pipeline developments

Integrating pharmacy benefit, medical benefit cuts costs

November 29, 2016

Here’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.

x